Session R.A. II
SEC CIK 1701846 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies, Inc. | Pres, CEO, Dir, 10% | 8.88M | $529.1K | $388.1K | 5 | 2021-11-23 | 2023-07-12 |
Most active insiders at TSHA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nagendran Sukumar | Pres, Head of R, D, Dir | — | $5.33M |
| 2 | Nolan Sean P. | CEO, Dir | — | $840.2K |
| 3 | Alam Kamran | CFO | — | $492.5K |
| 4 | Long Alison S | Dir | — | — |
| 5 | Sepp-Lorenzino Laura | Dir | — | — |
| 6 | Stalfort John A III | Dir | — | — |
| 7 | Donenberg Phillip B. | Dir | — | — |
Session R.A. II made no open-market trades at TSHA in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-07-14 | 2023-07-12+ | TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% | S - Sale | $0.7094 | -85.9K | 8.88M | -1.0% | -$60.9K |
| M | 2023-06-26 | 2023-06-22+ | TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% | S - Sale | $0.7 | -28.6K | 8.98M | -0.3% | -$20.0K |
| M | 2023-06-22 | 2023-06-20+ | TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% | S - Sale | $0.7068 | -434.6K | 9.13M | -5% | -$307.2K |
| D | 2023-03-08 | 2023-03-06 | TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | 10% | J - Other | $0.00 | +251.3K | 9.42M | +3% | $0 |
| M | 2021-12-08 | 2021-11-23 | TSHA | Taysha Gene Therapies, Inc. | Session R.A. II | Pres, CEO, Dir, 10% | P - Purchase | $12.44 | +42.5K | 9.19M | +0.5% | +$529.1K |
Purchase Sale Sale after option exercise All abbreviations